Immune failure, infection and survival in chronic lymphocytic leukemia in Denmark von Andersen, Michael Asger, Niemann, Carsten Utoft

Volltext

Deep immune cell phenotyping and induced immune cell responses at admission stratified by BMI in patients hospitalized with COVID-19: An observational multicenter cohort pilot stud... von Sejdic, Adin, Hartling, Hans Jakob, Gitz Holler, Jon, Klingen Gjærde, Lars, Matovu Dungu, Arnold, Engel Møller, Maria Elizabeth, Svanberg Teglgaard, Rebecca, Utoft Niemann, Carsten Utoft, Brooks, Patrick Terrence, Mogensen, Trine H., Weis, Nina, Podlekareva, Daria, Baum Jørgensen, Marie Louise, Ortved Gang, Anne, Stampe Hersby, Ditte, Hald, Annemette, Dam Nielsen, Susanne, Lebech, Anne-Mette, Helleberg, Marie, Lundgren, Jens, Træholt Franck, Kristina, Fischer, Thea K., Barrella Harboe, Zitta, Marquart, Hanne Vibeke, Rye Ostrowski, Sisse, Lindegaard, Birgitte

Volltext

Targeting Bruton’s Tyrosine Kinase Across B-Cell Malignancies von da Cunha-Bang, Caspar, Niemann, Carsten Utoft

Volltext

Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy von Helleberg, Marie, Niemann, Carsten Utoft, Moestrup, Kasper Sommerlund, Kirk, Ole, Lebech, Anne-Mette, Lane, Clifford, Lundgren, Jens

Volltext

Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study von Andersen, Michael Asger, Eriksen, Casper Tabassum, Brieghel, Christian, Biccler, Jorne Lionel, Cunha-Bang, Caspar da, Helleberg, Marie, Niemann, Carsten Utoft

Volltext

BTK inhibitors: safety + efficacy = outcome von Niemann, Carsten Utoft

Volltext

Immediate COVID-19 treatment in CLL von Niemann, Carsten Utoft

Volltext

IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study von Rotbain, Emelie Curovic, Frederiksen, Henrik, Hjalgrim, Henrik, Rostgaard, Klaus, Egholm, Gudrun Jakubsdottir, Zahedi, Banafsheh, Poulsen, Christian Bjorn, Enggard, Lisbeth, da Cunha-Bang, Caspar, Niemann, Carsten Utoft

Volltext

Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial von Jerkeman, Mats, Eskelund, Christian Winther, Hutchings, Martin, Räty, Riikka, Wader, Karin Fahl, Laurell, Anna, Toldbod, Helle, Pedersen, Lone Bredo, Niemann, Carsten Utoft, Dahl, Christina, Kuitunen, Hanne, Geisler, Christian H, Grønbæk, Kirsten, Kolstad, Arne

Volltext

Cost-effectiveness targeting CLL von Niemann, Carsten Utoft

Volltext

Immune cell populations and induced immune responses at admission in patients hospitalized with vaccine breakthrough SARS-CoV-2 infections von Sejdic, Adin, Hartling, Hans Jakob, Holler, Jon Gitz, Klingen Gjærde, Lars, Lindegaard, Birgitte, Dungu, Arnold Matovu, Gnesin, Filip, Møller, Maria Elizabeth Engel, Teglgaard, Rebecca Svanberg, Niemann, Carsten Utoft, Brooks, Patrick Terrence, Jørgensen, Charlotte Sværke, Franck, Kristina Træholt, Fischer, Thea K, Marquart, Hanne Vibeke, Harboe, Zitta Barrella, Ostrowski, Sisse Rye

Volltext

Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/... von Levin, Mark-David, Kater, Arnon, Mattsson, Mattias, Kersting, Sabina, Ranti, Juha, Thi Tuyet Tran, Hoa, Nasserinejad, Kazem, Niemann, Carsten Utoft

Volltext

Targeting Bruton’s Tyrosine Kinase Across B-Cell Malignancies von da Cunha-Bang, Caspar, Niemann, Carsten Utoft

Volltext

The CLL-IPI applied in a population-based cohort von da Cunha-Bang, Caspar, Christiansen, Ilse, Niemann, Carsten Utoft

Volltext

Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia von Andersen, Michael Asger, Grand, Mia Klinten, Brieghel, Christian, Siersma, Volkert, Andersen, Christen Lykkegaard, Niemann, Carsten Utoft

Volltext

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV von Klausen, Uffe, Grauslund, Jacob Handlos, Jørgensen, Nicolai Grønne Dahlager, Ahmad, Shamaila Munir, Jonassen, Merete, Weis-Banke, Stine Emilie, Martinenaite, Evelina, Pedersen, Lone Bredo, Lisle, Thomas Landkildehus, Gang, Anne Ortved, Enggaard, Lisbeth, Hansen, Morten, Holmström, Morten Orebo, Met, Özcan, Svane, Inge Marie, Niemann, Carsten Utoft, Pedersen, Lars Møller, Andersen, Mads Hald

Volltext

Deployment and validation of the CLL treatment infection model adjoined to an EHR system von Agius, Rudi, Riis-Jensen, Anders C., Wimmer, Bettina, da Cunha-Bang, Caspar, Murray, Daniel Dawson, Poulsen, Christian Bjorn, Bertelsen, Marianne B., Schwartz, Berit, Lundgren, Jens Dilling, Langberg, Henning, Niemann, Carsten Utoft

Volltext

P599: ACALABRUTINIB IMPROVES INNATE IMMUNE FUNCTION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA von Teglgaard, Rebecca, Rye Ostrowski, Sisse, Da Cunha‐Bang, Caspar, Brieghel, Christian, Faitová, Tereza, Enggaard, Lisbeth, Jakob Hartling, Hans, Vibeke Hansen Marquart, Hanne, Utoft Niemann, Carsten

Volltext

Polypharmacy Independently Predicts Overall Survival in Patients with Lymphoid Cancer von Brieghel, Christian, Rotbain, Emelie Curovic, Andersen, Michael Asger, Brown, Peter de Nully, Niemann, Carsten Utoft

Volltext

Medical history and lifestyle factors have limited impact on time‐to‐first‐treatment in patients with chronic lymphocytic leukemia von Glimelius, Ingrid, Kleinstern, Geffen, Robinson, Dennis P., Mansouri, Larry, Rostgaard, Klaus, Hjalgrim, Henrik, Niemann, Carsten Utoft, Mattsson, Mattias, Rabe, Kari G., Hampel, Paul J., Parikh, Sameer A., Rosenquist, Richard, Cerhan, James R., Slager, Susan L., Smedby, Karin E.

Volltext